Inhibition of polyamine biosynthesis preserves β cell function in type 1 diabetes
Emily K. Sims(University School), Linda A. DiMeglio(Urology of Indiana), Susan M. Perkins(Indiana University School of Medicine), Bobbie‐Jo Webb‐Robertson(Pacific Northwest National Laboratory), Susanne M. Cabrera(Medical College of Wisconsin), Soumyadeep Sarkar(Pacific Northwest National Laboratory), Raghavendra G. Mirmira(University of Chicago), Abhishek Kulkarni(University of Minnesota), Ernesto Nakayasu(Pacific Northwest National Laboratory), Lucy D. Mastrandrea(University at Buffalo, State University of New York), Jacob R. Enriquez(University of Chicago), S. Alice Long(Benaroya Research Institute), Carmella Evans‐Molina(Richard L. Roudebush VA Medical Center), Teresa L. Mastracci(Indiana University Indianapolis), Fangqian Ouyang(Indiana University School of Medicine), Lori Blanchfield(Benaroya Research Institute), Sarah A. Tersey(Diabetes Australia), Eugene W. Gerner(University of North Carolina at Chapel Hill), Batoul Hammoud(Children's Hospital of Philadelphia), Audrey Hull(Nationwide Children's Hospital), Stéphanie Woerner(Délégation Paris 7)
Cited by 26
Related Papers
Restructuring of the Gut Microbiome by Intermittent Fasting Prevents Retinopathy and Prolongs Survival in <i>db/db</i> Mice
|Diabetes|2018|385
Introducing the Endotype Concept to Address the Challenge of Disease Heterogeneity in Type 1 Diabetes
|Diabetes Care|2019|350
ADCK4 mutations promote steroid-resistant nephrotic syndrome through CoQ10 biosynthesis disruption
|Journal of Clinical Investigation|2013|341
Review, Evaluation, and Discussion of the Challenges of Missing Value Imputation for Mass Spectrometry-Based Label-Free Global Proteomics
|Journal of Proteome Research|2015|318
The Cancer Microbiome: Distinguishing Direct and Indirect Effects Requires a Systemic View
|Trends in cancer|2020|266